4BIO Capital Portfolio Company Ray Therapeutics Closes Oversubscribed $100M Series A Financing to Advance Optogenetic Gene Therapies for Blinding Diseases Press Release 4BIO Capital Portfolio Company Ray Therapeutics Closes Oversubscribed $100M Series A Financing to Advance Optogenetic Gene Therapies for Blinding Diseases Series A follows initial seed...

4BIO Capital Leads $6 Million Seed Financing in Ray Therapeutics Press Release 4BIO Capital Leads $6 Million Seed Financing in Ray Therapeutics 4 January 2022 LONDON & BOSTON – 4BIO Capital (“4BIO” or “the Group”), an international venture capital firm...

4BIO Capital Leads $6 Million Seed Financing in Ray Therapeutics Press Release 4BIO Capital Leads $6 Million Seed Financing in Ray Therapeutics 4 January 2022 LONDON & BOSTON – 4BIO Capital (“4BIO” or “the Group”), an international venture capital firm...